Latest Partnerships News

Transurban Group is streamlining operations with a workforce reduction of approximately 300 employees, aiming to save over $50 million annually while maintaining its FY25 distribution guidance.

Memphasys Limited has successfully trialed its RoXsta™ Mega Cell High-Throughput Assay, capable of processing 96 antioxidant tests in under an hour, promising a leap forward in rapid, cost-effective oxidative stress analysis.

Pointerra Limited has joined forces with Leidos as a subcontractor on the US Army’s $499 million GRIDS IV program, aiming to enhance real-time geospatial intelligence through advanced AI and machine learning technologies.

Titan Minerals and partner Hanrine have nearly doubled the known porphyry copper mineralisation at the Linderos Copper Project in Ecuador, with ongoing drilling confirming a large-scale system open in multiple directions.

Guzman y Gomez has unveiled an ambitious expansion and margin improvement plan at the 2025 Macquarie Australia Conference, reaffirming its FY25 guidance and spotlighting strong franchise growth and operational excellence.

Smartgroup reports a solid start to 2025 with stable revenue and a surge in electric vehicle leasing orders, while cautiously navigating evolving government incentives and market conditions.

Tivan Limited has had its trading suspension lifted following the announcement of a binding joint venture and funding agreement for its Speewah Fluorite Project, signaling renewed momentum for the company.

Tivan Limited and Sumitomo Corporation have formalised a joint venture to develop the Speewah Fluorite Project in Western Australia, marking a major step toward establishing Australia’s inaugural fluorite mining and processing operation.

Alterity Therapeutics is set to present compelling Phase 2 clinical trial results for ATH434 at the 2025 International Multiple System Atrophy Congress, highlighting slowed disease progression and biomarker engagement in MSA patients.

Tivan Limited’s shares have been suspended at the company’s request pending a major joint venture announcement and its response to an ASX compliance query.

Echo IQ has raised $17.3 million through a strongly supported institutional placement to fund US commercialization and FDA approval efforts for its EchoSolv AI cardiology products.

Almonty Industries has secured a binding offtake agreement to supply tungsten oxide exclusively for U.S. defense applications, guaranteeing steady demand and pricing for the next three years.